Primary Biliary Cholangitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with a liver condition called PSC (Primary Sclerosing Cholangitis) who are between 18 and 85 years old at the time of joining the study.
- People diagnosed with a liver condition called PBC (Primary Biliary Cholangitis) who are between 18 and 85 years old at the time of joining the study.
- People with PSC or PBC who have previously had a liver transplant may still be able to join, though they would not be able to take part in a specific bile collection procedure.
- Women with PSC or PBC who are pregnant or could become pregnant are welcome to join, as the study poses no known risk to an unborn child.
- Healthy people with no history of PSC, PBC, or any other long-term liver disease, who are between 18 and 85 years old, may join as a comparison (control) group.
- People between 18 and 85 who do not have PSC or PBC but do have another type of long-term liver disease may also be able to join as a comparison group.
Who may not be able to join:
- People with PSC or PBC who also have another long-term liver disease at the same time.
- People who are not able to give their own informed consent to participate in the study.
- People who are currently in prison or living in an institution.
- People with PSC who have had a liver transplant will not be able to take part in the bile collection procedure specifically.
- People who have previously had a type of bowel surgery called a Roux-en-Y procedure will not be able to take part in the bile collection procedure specifically.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Konstantinos Lazaridis, M.D., Mayo Clinic
Phone: 507-284-4312
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants in the study.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.